Tharimmune Stock Gains 30%, on $540M Capital Raise to Build Canton Coin Treasury Strategy

The nanocap biotech firm is pivoting into digital assets with a $540 million raise to build a canton coin–based treasury, backed by DRW and Liberty City Ventures.